LONDON and NEW YORK - OKYO Pharma Limited (NASDAQ: OKYO), a biopharmaceutical company specializing in the development of treatments for ocular conditions and currently valued at $37 million, has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback